Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era

Ayman Elbadawi; Dhruv Mahtta; Islam Y. Elgendy; Marwan Saad; Chayakrit Krittanawong; Ravi S. Hira; Mohamed Omer; Gbolahan O. Ogunbayo; Kirk Garratt; Sunil V. Rao; Hani Jneid

doi:10.1016/j.jcin.2020.07.004

Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era

Ayman Elbadawi
, Dhruv Mahtta
, Islam Y. Elgendy
, Marwan Saad
, Chayakrit Krittanawong
, Ravi S. Hira
, Mohamed Omer
, Gbolahan O. Ogunbayo
, Kirk Garratt
, Sunil V. Rao
, Hani Jneid

Producción científica: Letter › revisión exhaustiva

4 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	2312-2314
Número de páginas	3
Publicación	JACC: Cardiovascular Interventions
Volumen	13
N.º	19
DOI	https://doi.org/10.1016/j.jcin.2020.07.004
Estado	Published - oct 12 2020

Financiación

Dr. Garratt has received honoraria for serving on clinical events adjudication committees from Abbott Vascular and Jarvik Heart; and is a cofounder of and holds an equity position in LifeCuff Technologies, Inc. Dr. Rao has received research funding to his institution from Bayer, Shockwave Medical, and Svelte Medical. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. †Drs. Elbadawi and Mahtta contributed equally to this work.

Financiadores
LifeCuff Technologies, Inc.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Acceder al documento

10.1016/j.jcin.2020.07.004

Otros archivos y enlaces

Citar esto

@article{b69db995d8f84f2a8b11c9a8ce7575be,

title = "Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era",

author = "Ayman Elbadawi and Dhruv Mahtta and Elgendy, \{Islam Y.\} and Marwan Saad and Chayakrit Krittanawong and Hira, \{Ravi S.\} and Mohamed Omer and Ogunbayo, \{Gbolahan O.\} and Kirk Garratt and Rao, \{Sunil V.\} and Hani Jneid",

year = "2020",

month = oct,

day = "12",

doi = "10.1016/j.jcin.2020.07.004",

language = "English",

volume = "13",

pages = "2312--2314",

number = "19",

}

TY - JOUR

T1 - Trends and Outcomes of Fibrinolytic Therapy for STEMI

T2 - Insights and Reflections in the COVID-19 Era

AU - Elbadawi, Ayman

AU - Mahtta, Dhruv

AU - Elgendy, Islam Y.

AU - Saad, Marwan

AU - Krittanawong, Chayakrit

AU - Hira, Ravi S.

AU - Omer, Mohamed

AU - Ogunbayo, Gbolahan O.

AU - Garratt, Kirk

AU - Rao, Sunil V.

AU - Jneid, Hani

PY - 2020/10/12

Y1 - 2020/10/12

UR - https://www.scopus.com/pages/publications/85091697525

UR - https://www.scopus.com/pages/publications/85091697525#tab=citedBy

U2 - 10.1016/j.jcin.2020.07.004

DO - 10.1016/j.jcin.2020.07.004

M3 - Letter

C2 - 33032721

AN - SCOPUS:85091697525

SN - 1936-8798

VL - 13

SP - 2312

EP - 2314

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

IS - 19

ER -

Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era

Financiación

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto